Head-To-Head Comparison: CryoPort (NASDAQ:CYRX) and Jungheinrich (OTCMKTS:JGHAF)

Jungheinrich (OTCMKTS:JGHAF) and CryoPort (NASDAQ:CYRX) are both transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Jungheinrich and CryoPort’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jungheinrich	N/A	N/A	N/A
CryoPort	42.35%	-8.22%	-4.84%

Earnings & Valuation

This table compares Jungheinrich and CryoPort”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jungheinrich	$5.84 billion	0.38	$312.72 million	N/A	N/A
CryoPort	$176.18 million	2.93	$78.30 million	$1.32	7.84

Jungheinrich has higher revenue and earnings than CryoPort.

Insider & Institutional Ownership

92.9% of CryoPort shares are owned by institutional investors. 10.0% of CryoPort shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Jungheinrich and CryoPort, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jungheinrich	0	0	0	0	0.00
CryoPort	1	1	7	0	2.67

CryoPort has a consensus target price of $13.31, suggesting a potential upside of 28.62%. Given CryoPort’s stronger consensus rating and higher possible upside, analysts clearly believe CryoPort is more favorable than Jungheinrich.

Volatility & Risk

Jungheinrich has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.

Summary

CryoPort beats Jungheinrich on 8 of the 12 factors compared between the two stocks.

About Jungheinrich

Jungheinrich Aktiengesellschaft, through its subsidiaries, provides products and solutions for the intralogistics sector with a portfolio of material handling equipment, automated systems, and matching services worldwide. It operates in two segments, Intralogistics and Financial Services. The Intralogistics segment engages in the development, production, sale, and short-term rental of new material handling equipment and warehousing equipment products, including automation; sale and short-term leasing of used trucks; and provides spare parts, as well as maintenance and repair services. The Financial Services segment engages in the sales financing and usage transfer of material handling and warehousing equipment products. The company's products include electric and hand pallet trucks, electric pallet stackers; order pickers; reach trucks; very narrow aisle trucks and EKX cold store high rack stacker; electric forklift; tow tractors, tugger train trailers, shuttles, and used forklift trucks. It also offers rental of fleet, and battery and charger; contract and event hire service; automated guided vehicles, conveyor technology, and stacker cranes; lithium-ion and lead-acid batteries; charging technology; powertrain solutions; electric drives/drivetrains; controllers; electromechanics components/control pedals/displays; electric mounting panels; and cable sets. In addition, the company provides warehouse racking and storage services; digital products and software solutions, including warehouse management system, fleet management system, device and process management solutions, and interface management; and wi-fi infrastructure, barcode scanners, and mobile workstations; as well as develops software applications. It distributes its products through its direct sales and service network, as well as through dealers. Jungheinrich Aktiengesellschaft was founded in 1953 and is headquartered in Hamburg, Germany.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.